HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Craig, J. C. Articles by Howman-Giles, R. B. Search for Related Content PubMed PubMed Citation Articles by Craig, J. C. Articles by Howman-Giles, R. B.

How Accurate Is Dimercaptosuccinic Acid Scintigraphy for the Diagnosis of Acute Pyelonephritis? A Meta-Analysis of Experimental Studies

Center for Kidney Research and Department of Nuclear Medicine, The New Children's Hospital, Sydney
Department of Public Health and Community Medicine, and Department of Paediatrics and Child Health, University of Sydney, Sydney, Australia

Correspondence: For correspondence or reprints contact: Jonathan C. Craig, PhD, Center for Kidney Research, The New Children's Hospital, PO Box 3515, Parramatta, NSW 2124, Australia.

ABSTRACT

The purpose of this study was to evaluate the performance of dimercaptosuccinic acid (DMSA) scintigraphy in the diagnosis of acute pyelonephritis and to compare the test performance of the standard technique, planar DMSA, with the newly introduced technique, SPECT DMSA. Methods: All published animal studies in which DMSA scintigraphy was compared with histopathology, the reference standard for acute pyelonephritis, were identified using a comprehensive search strategy with the MEDLINE and EMBASE databases. Test performances of all DMSA methods and SPECT versus planar DMSA were analyzed using summary receiver operating characteristic (sROC) curves. Results: Seven studies were identified, including 2 of SPECT DMSA. Problems in study design or reporting were common, with numerical errors in 4 studies. Overall, at a sensitivity of 86%, specificity was estimated to be 91%. Detection of acute pyelonephritis was at a lower threshold for SPECT than for planar DMSA (sensitivity/specificity values of 97%/66% compared with 82%/ 97%), and the overall test performance of SPECT was not demonstrably better than that of planar DMSA. When applied to a group of children with a prevalence of renal damage of 40%, this means that 98% of children with abnormal planar DMSA scans will have renal damage, whereas only 65% of those with abnormal SPECT scans will have renal damage. Planar and SPECT DMSA will miss 11% and 3% of children with renal damage, respectively. Out of 100 children in the hypothetical group with 40% experiencing renal damage, SPECT will identify 6 extra true cases of renal damage at the expense of 19 extra false positives, when compared with planar DMSA. Conclusion: Published studies of DMSA test performance are few in number and have significant methodologic problems that should be avoided in future studies. DMSA, particularly the planar technique, performs well for the diagnosis of acute pyelonephritis. Using test performance criteria, SPECT DMSA alone has not been shown to be preferable to the established planar method and will result in a small number of true-positives at the expense of a larger number of false-positives.

Key Words: dimercaptosuccinic acid • pyelonephritis • diagnosis • systematic review • sensitivity

This article has been cited by other articles:

				A. Hitzel, A. Liard, P. Vera, A. Manrique, J.-F. Menard, and J.-N. Dacher Color and Power Doppler Sonography Versus DMSA Scintigraphy in Acute Pyelonephritis and in Prediction of Renal Scarring J. Nucl. Med., January 1, 2002; 43(1): 27 - 32. [Abstract] [Full Text] [PDF]